Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest biotechnology Stories

2014-03-28 08:26:18

IRVING, Texas, March 28, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, continues to enhance its industry-leading comprehensive tumor profiling service, Caris Molecular Intelligence(TM), now capable of providing an industry-leading 51 drug target associations, including exciting new immunologically-based drug targets. Through these enhancements, Caris Molecular Intelligence will now provide...

2014-03-27 16:24:57

CLEVELAND, March 27, 2014 /PRNewswire/ -- Jake Orville, CEO of Cleveland HeartLab, accepted today the Crystal Award for Excellence from Ohio's Edison Technology Centers. The presentation was made by its Edison Centers Director Council during a luncheon held at the Ohio statehouse and attended by state legislators and executives from other innovative companies. http://photos.prnewswire.com/prnvar/20140205/CL59890LOGO The six Edison Technology Centers located in Ohio provide a...

2014-03-27 12:31:03

LONDON, March 27, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global and China Monoclonal Antibody Industry Report, 2013-2017 Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents grew at a CAGR of 13%, far higher than the overall growth rate of...

2014-03-27 12:30:38

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rwdz5w/therapy_class ) has announced the addition of the "Therapy Class Overview: Rituximab biosimilar" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Approval of Inflectra/Remsima, the first biosimilar Monoclonal antibody (Mab) from Celltrion and Hospira in EU in 2013 is a trend setter! Inflectra is a biosimilar of Johnson & Johnson's Remicade,...

2014-03-27 12:29:43

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3xxp4l/global ) has announced the addition of the "Global Pharmaceutical and Biotechnology Outlook 2014: Rising Stars" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Innovations have contributed to the availability of a range of new treatments for diseases resulting in improvements in the length and quality of life and reduced disease burden for...

2014-03-27 08:33:57

DUBLIN, Mar. 27, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/x6dsmh/therapeutic_class) has announced the addition of the "Therapeutic Class Overview : Emergence of Biogenerics Era In Japan - It's Time to Welcome Antibody Biosimilars of Foreign Origins Soon" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) With three products and eight players already in market - Japan biosimilar market will enter new phase...

2014-03-27 08:33:24

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3clltz/global ) has announced the addition of the "Global Pharmaceutical and Biotechnology Outlook 2014 - India Pharma" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Indian companies are taking center stage in Complex Generics at US and EU markets. In Bio-similars, Indian companies will have perhaps the largest basket aimed at Emerging Countries in...

2014-03-26 23:30:02

RSCI’s one-day treatment program in Florida, USA, is priced to bring stem cell treatment benefits to the greatest possible number of SCI patients. Dallas, TX (PRWEB) March 26, 2014 The Repair Stem Cells Institute (RSCI – http://www.repairstemcells.org) announces its new “Double Benefits for SCI” stem cell treatment program specifically to benefit sufferers of Spinal Cord Injuries (SCI). The Regenerative Center, headed by Dr. Melvin M. Propis, a well-known practitioner of stem...

2014-03-26 23:29:10

Stemedica Cell Technologies, Inc., a specialty biopharmaceutical company that manufactures best-in-class allogeneic adult stem cells and Smart Living, a subsidiary of Smart Global, a $2 billion (USD) globally diversified conglomerate, are pleased to announce an international educational collaboration. San Diego, CA (PRWEB) March 26, 2014 Stemedica Cell Technologies, Inc., a specialty biopharmaceutical company that manufactures best-in-class allogeneic adult stem cells and Smart Living, a...

2014-03-26 23:27:06

Just in time for Earth Month, Natural Merchants announces the Non-GMO Project Verification of its core portfolio wines. Grants Pass, OR (PRWEB) March 26, 2014 Just in time for Earth Month, Natural Merchants, LLC, based in Grants Pass, OR and Cartagena, Spain, announces the Non-GMO Project Verification of its core portfolio wines, the first wines imported from Europe to obtain the verification. Sponsored by the Non-GMO Project, the Non-GMO Challenge encourages consumers to make a...


Latest biotechnology Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Genetically Modified Wheat
2013-10-02 07:20:35

Genetically Modified Wheat is wheat that has been genetically engineered by the direct manipulation of its genome utilizing biotechnology. It has also been termed GMO wheat, GMO standing for genetically modified organism. As of the year 2013, no GM wheat is grown commercially, but many field tests have been performed. Wheat is an important domesticated grass that is used around the world for food, and its evolution has been influenced by human intervention since the dawn of agriculture....

Biotechnology and Applied Biochemistry
2012-06-04 19:33:04

Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...

More Articles (7 articles) »